Suramin inhibits vasoactive intestinal peptide (VIP) binding and VIP-induced cAMP accumulation into two human cancerous cell lines. [electronic resource]
Producer: 19920610Description: 163-71 p. digitalISSN:- 0895-7479
- Cross-Linking Reagents
- Cyclic AMP -- metabolism
- Humans
- Iodine Radioisotopes
- Isoproterenol -- pharmacology
- Protein Binding
- Receptors, Gastrointestinal Hormone -- chemistry
- Receptors, Vasoactive Intestinal Peptide
- Succinimides
- Suramin -- pharmacology
- Tumor Cells, Cultured
- Vasoactive Intestinal Peptide -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.